Meet Zach, a forever 18 year old osteosarcoma warrior. Zach was a compassionate and loving soul with a passion for living life to the fullest.
Cancer
Affordable Care Act key to keeping people insured amid COVID 19-related job losses
Widespread layoffs amid the COVID-19 pandemic threaten to cut off millions of people from their employer-sponsored health insurance plans.
Short-term exposure to air pollution linked with new causes of hospital admissions, substantial economic costs
Hospitalizations for several common diseases—including septicemia (serious bloodstream infection), fluid and electrolyte disorders, renal failure, urinary tract infections, and skin and tissue infections—have been linked for the first time with short-term exposure to fine particulate air pollution (PM2.5), according to a comprehensive new study led by Harvard T.H. Chan School of Public Health.
Overall cancer mortality continues to decline in the US
Cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016, according to the latest Annual Report to the Nation on the Status of Cancer.
Promising urine DNA test could facilitate detection of urothelial cancer
Scientists at the International Agency for Research on Cancer (IARC), in collaboration with researchers at the Protestant Clinic of Lyon (France), the Portuguese Oncology Institute of Porto (Portugal), and Lomonosov Moscow State University (Russian Federation), have developed a simple, sensitive, and specific urine test (called UroMuTERT) that is capable of detecting urothelial cancer (carcinoma of the bladder and of the upper urinary tract).
Nearly half of childhood cancers worldwide undiagnosed
Nearly half of all childhood cancers are not being diagnosed globally, according to a new modeling study led by Harvard T.H. Chan School of Public Health.
IARC publication highlights variations in cancer incidence, survival, and mortality that exist between countries
A new Scientific Publication from the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO), has examined the global problem of social inequalities in cancer, highlighting the large variations in cancer incidence, survival, and mortality that exist between countries.
